Related Experiment Video
Updated: Nov 29, 2025

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
[COVID-19 and stroke]
Kuniyasu Wada1, Yoichiro Hashimoto1, Makoto Nakajima2
1Department of Neurology, Kumamoto City Hospital.
Insights
The COVID-19 pandemic disrupted stroke care, decreasing consultations and procedures. Stroke in COVID-19 patients often presents as ischemic, affects younger individuals, and is linked to high D-dimer levels and cardiovascular risks.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic significantly impacted healthcare systems globally.
- Stroke care pathways experienced disruptions, including reduced patient consultations and fewer thrombectomy procedures.
- Understanding stroke characteristics in COVID-19 patients is crucial for adapting medical care.
Purpose of the Study:
- To summarize the changes in stroke medical care systems during the COVID-19 pandemic.
- To elucidate the specific features and incidence of stroke in patients with COVID-19.
- To introduce the concept of Protected Code Stroke (PCS) for safe and effective treatment.
Main Methods:
- Review of changes in stroke care during the pandemic.
- Analysis of stroke incidence and characteristics in COVID-19 patients.
- Description of the Protected Code Stroke (PCS) protocol.
Main Results:
- Stroke incidence in COVID-19 patients is approximately 1.1%.
- Stroke in COVID-19 patients is predominantly ischemic, with a notable increase in younger individuals.
- Higher D-dimer levels and pre-existing cardiovascular risk factors (hypertension, diabetes) are associated with increased stroke risk in elderly COVID-19 patients.
- Venous thromboembolism is more frequent than arterial thromboembolism in COVID-19 patients.
Conclusions:
- The COVID-19 pandemic necessitated significant adaptations in stroke care delivery.
- Stroke in COVID-19 patients exhibits distinct features requiring tailored management strategies.
- Protected Code Stroke (PCS) offers a framework for safe, effective, and prompt stroke treatment under infection control measures.
Abstract:
Due to the pandemic of corona virus disease 2019 (COVID-19), the stroke medical care system is unavoidably undergoing major changes such as a decrease in the number of stroke patients receiving consultation, delay in consultation, and a decrease in the number of intravenous thrombolysis and mechanical thrombectomy procedures. Stroke incidence in COVID-19 patients is approximately 1.1%. The features of stroke with COVID-19 have been elucidated: higher incidence in ischemic stroke than hemorrhagic stroke, increasing number of young patients, high D-dimer levels, and higher risk in elderly patients with cardiovascular risk factors such as hypertension and diabetes. In patients with COVID-19, venous thromboembolism is more common than arterial thromboembolism, and stroke is more common than acute coronary syndrome. Protected code stroke (PCS) has been proposed which provides safe, effective and prompt treatment under complete infection control.
Related Concept Videos
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis IV: Nursing Management
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

